Tag

Foundayo

All articles tagged with #foundayo

markets2 days ago•3 min saved

Lilly Obesity Drugs Lag Wegovy in Early Prescription Data, Weighing on Stock

Premarket, Eli Lilly shares fell after IQVIA data cited by Bloomberg showed Lilly’s obesity drugs Foundayo (oral) and Zepbound trailed Novo Nordisk’s Wegovy in weekly prescriptions; Zepbound fell about 2% week over week while Wegovy rose about 7% in the same period, and Foundayo posted 3,707 prescriptions in its first full week versus Wegovy’s roughly 18,410 in its first full week; analysts caution that one week of data isn’t definitive, but weak early momentum could pressure Lilly stock if the trend persists.

via Seeking Alpha|

#eli-lilly #foundayo #markets

markets10 days ago•14 min saved

Lilly’s Foundayo Launch Triggers Fresh Buy rating Amid Strong Demand Forecasts

BMO Capital Markets reiterates a Buy-equivalent rating on Eli Lilly (LLY) with a $1,300 target as the obesity pill Foundayo rolls out. Lilly expects $1.5–$2.8 billion in U.S. sales this year and up to $36 billion in peak annual sales globally, with Foundayo distributed through Weight Watchers (WW) and Amazon among other channels. The FDA approved Foundayo on April 1, and Wall Street remains bullish, with a consensus Strong Buy from 19 analysts and an average target around $1,247, implying roughly 31% upside from current levels.

via TipRanks|

#amzn #bmo #foundayo

healthcare10 days ago•14 min saved

Lilly’s Foundayo earns non-inferiority and cardiometabolic gains in ACHIEVE-4, fueling FDA submission

In ACHIEVE-4, the largest/longest Phase 3 trial of Foundayo (orforglipron) vs insulin glargine in adults with type 2 diabetes at high CV risk, Foundayo met non-inferiority for MACE-4 and showed 16% lower risk for MACE-4 and 23% lower risk for MACE-3; a pre-planned analysis also showed 57% lower risk of all-cause death. The study (2,700+ participants across 15 countries) demonstrated sustained A1C and body-weight improvements through 104 weeks. Lilly intends to submit Foundayo to the FDA for type 2 diabetes by end of Q2.

via Eli Lilly|

#achieve-4 #cardiovascular-safety #foundayo

business17 days ago•5 min saved

Amazon Pharmacy Lands Lilly’s Foundayo GLP-1 Pill for Same-Day Delivery

Amazon Pharmacy will offer Eli Lilly’s new oral GLP-1 drug Foundayo with real-time availability and transparent pricing (insurance as low as $1/day or $25/mo; cash $5/day or $149/mo; automatic coupons), plus Same-Day Delivery nationwide and pharmacist-supported in-office kiosks at select One Medical locations, expanding access from about 3,000 to 4,500 cities by year-end; remote areas will have next-day to three-day delivery.

via Business Wire|

#amazon-pharmacy #business #eli-lilly